AST podcasts and recordings


July 15, 2009

In this podcast, Dr. Nader Najafian, Assistant Professor of Medicine at Harvard Medical School and Associate Physician at the Brigham and Women's Hospital in Boston, discusses the role of various T-regulatory cells in normal humans and after organ transplantation. He describes the influence of various immunosuppressive agents on the frequencies of T - regulatory cells and speculates on future strategies that might be used to expand and exploit the beneficial effects of these cells.

June 23, 2009

Dr. Nina Singh is the Associate Professor of Medicine at the University of Pittsburgh and Chief of Transplant Infectious Diseases at the VA Medical Center. In this podcast, Dr. Singh discusses the epidemiology of fungal infections in transplant recipients and the need for antifungal prophylaxis especially after liver and lung transplant. She further discusses the advantages/disadvantages of various antifungal medications that can be used for prophylaxis and molecular testing for fungal infections.

May 20, 2009

In this podcast, Dr. Vikas Dharnidharka, Chair of the Executive Committee of the AST Pediatric Community of Practice, interviews Dr. William Harmon, Pediatric Nephrology Division Chief of Childrens Hospital, Boston. Dr. Harmon, a past president of the American Society of Transplantation, is also a leader in the science of transplanting kidneys to very young children. In this podcast, Harmon reviews why infants had poor results with kidney transplantation in the older era and the advances that have led to the current era, where infants now how have the best long-term results among all age groups that receive kidney transplants.

E.g., 07/12/2024
E.g., 07/12/2024
Join today to receive exclusive benefits.
View my membership
December 31, 2008

Dr. Emilio Poggio is the Associate Staff Member of the Department of Nephrology and Hypertension and the Director of the Renal Function Laboratory at the Cleveland Clinic Foundation. This podcast discusses the importance of accurately measuring GFR in potential donors and advice given to potential donors who inquire about changes in GFR post-donation.

November 10, 2008

Dr. Vikas Dharnidharka is Associate Professor of Pediatrics at the University of Florida and Medical Director of the Pediatric Kidney Transplant Program at Shands Hospital. In this podcast, Dr. Dharnidharka discusses the influence of organ failure on growth and development, treatment strategies for maximizing growth in the presence of organ failure, and the effects of organ transplantation on growth and development. He further discusses the benefits and risks of treatment with growth hormone, and the potential benefits of steroid-free imunosuppression in pediatric transplantation.

October 30, 2008

Dr. Atul Humar, Associate Professor of Medicine at the University of Alberta interviews Dr. Raymund Razonable expert in CMV infections and Associate Professor, Division of Infectious Diseases at the Mayo Clinic, Rochester, regarding CMV infection in transplant recipients. The focus of this podcast is on prevention strategies for CMV. This includes a discussion on prophylaxis and pre-emptive strategies and how the two compare for preventing CMV disease. Practical guidance on disease prevention is discussed. 

September 19, 2008

In this podcast, Dr. Margaret Bia describes the incidence and causes of sexual dysfunction, including decreased libido in both genders and erectile dysfunction in men, after organ transplantation. She emphasizes the need for talking openly to patients about sexual issues and discusses her own approach to evaluation and treatment.

April 17, 2008

Dr. David Briscoe, Associate Professor of Medicine and Pediatrics at the Harvard Medical School and staff member at the Children's Hospital Boston, discusses the general role of vascular endothelial growth factor (VEGF) in endothelial cell biology. Dr. Briscoe also describes the complex interplay between TOR signaling and the actions of VEGF. Finally, speculates on whether down regulation of VEGF accounts for the anti-neoplastic and proteinuric effects of TOR inhibition.

April 10, 2008

Dr. Emily Blumberg, an infectious diseases specialist and Associate Professor of Medicine with the University of Pennsylvania, interviews Dr. Michael Green on the topic of Epstein-Barr Virus and Post-Transplant Lymphoproliferative Disease (PTLD) and the Transplant Patient. Dr. Green is Professor of Pediatrics and Surgery in the Division of Infectious Diseases at the Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine.

January 28, 2008

Dr. Emily Blumberg, Associate Professor of Medicine at the University of Pennsylvania interviews Dr. Robin Avery, section head of Transplant and Infectious Diseases and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. The topic is Immunization in the Transplanted Patient.


Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.